These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 32296423)

  • 1. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.
    Thompson S; Martínez-Burgo B; Sepuru KM; Rajarathnam K; Kirby JA; Sheerin NS; Ali S
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Chemokine and Glycosaminoglycan Interaction in Chemokine-Mediated Migration In Vitro and In Vivo.
    del Molino del Barrio I; Kirby J; Ali S
    Methods Enzymol; 2016; 570():309-33. PubMed ID: 26921953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.
    McNaughton EF; Eustace AD; King S; Sessions RB; Kay A; Farris M; Broadbridge R; Kehoe O; Kungl AJ; Middleton J
    J Immunol; 2018 May; 200(9):3201-3217. PubMed ID: 29572348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte extravasation: chemokine transport and presentation by the endothelium.
    Middleton J; Patterson AM; Gardner L; Schmutz C; Ashton BA
    Blood; 2002 Dec; 100(12):3853-60. PubMed ID: 12433694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
    Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
    J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo.
    Li S; Pettersson US; Hoorelbeke B; Kolaczkowska E; Schelfhout K; Martens E; Kubes P; Van Damme J; Phillipson M; Opdenakker G
    PLoS One; 2014; 9(8):e104107. PubMed ID: 25093679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
    Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
    J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
    Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
    J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus.
    Heidarieh H; Alcamí A
    J Biol Chem; 2018 Nov; 293(45):17418-17429. PubMed ID: 30257868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling heparin-chemokine interactions using synthetic tools.
    de Paz JL; Moseman EA; Noti C; Polito L; von Andrian UH; Seeberger PH
    ACS Chem Biol; 2007 Nov; 2(11):735-44. PubMed ID: 18030990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
    Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
    J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
    Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
    Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
    Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
    Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines have diverse abilities to form solid phase gradients.
    Patel DD; Koopmann W; Imai T; Whichard LP; Yoshie O; Krangel MS
    Clin Immunol; 2001 Apr; 99(1):43-52. PubMed ID: 11286540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.